S&P 500

5.302,85

0,11%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Alvontech (ALVO)
Alvontech (ALVO) Notícias

ALVO

Alvontech (ALVO)

Alvontech

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ALVO

1 2 3 4 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
13/05/2024	09:00	GlobeNewswire Inc.	Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (12 noon GMT)	NASDAQ:ALVO	Alvontech
02/05/2024	08:15	GlobeNewswire Inc.	Alvotech Announces Participation at BofA Securities Healthcare Conference 2024	NASDAQ:ALVO	Alvontech
30/04/2024	05:00	Business Wire	U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)	NASDAQ:ALVO	Alvontech
24/04/2024	05:00	GlobeNewswire Inc.	Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)	NASDAQ:ALVO	Alvontech
19/04/2024	07:10	GlobeNewswire Inc.	Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)	NASDAQ:ALVO	Alvontech
16/04/2024	18:43	Business Wire	Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)	NASDAQ:ALVO	Alvontech
03/04/2024	08:41	GlobeNewswire Inc.	Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024	NASDAQ:ALVO	Alvontech
22/03/2024	17:15	GlobeNewswire Inc.	Alvotech Announces Increase in Number of Own Shares	NASDAQ:ALVO	Alvontech
20/03/2024	17:15	GlobeNewswire Inc.	Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update	NASDAQ:ALVO	Alvontech
20/03/2024	08:17	IH Market News	U.S. Index Futures Trade Sideways Amid Anticipation of Fed’s Policy Update; Oil Prices Dip	NASDAQ:ALVO	Alvontech
05/03/2024	18:00	GlobeNewswire Inc.	Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET	NASDAQ:ALVO	Alvontech
29/02/2024	18:05	GlobeNewswire Inc.	Alvotech Appoints Interim Chief Quality Officer	NASDAQ:ALVO	Alvontech
26/02/2024	06:25	GlobeNewswire Inc.	Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per Share	NASDAQ:ALVO	Alvontech
23/02/2024	22:15	GlobeNewswire Inc.	Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®	NASDAQ:ALVO	Alvontech
23/02/2024	22:15	Business Wire	Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®	NASDAQ:ALVO	Alvontech
15/02/2024	08:30	GlobeNewswire Inc.	Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)	NASDAQ:ALVO	Alvontech
29/01/2024	06:00	GlobeNewswire Inc.	Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®	NASDAQ:ALVO	Alvontech
19/01/2024	14:31	Dow Jones News	Alvotech Shares Climb After FDA Concludes Facility Inspection	NASDAQ:ALVO	Alvontech
19/01/2024	13:30	GlobeNewswire Inc.	Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04	NASDAQ:ALVO	Alvontech
10/01/2024	05:30	GlobeNewswire Inc.	STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara	NASDAQ:ALVO	Alvontech
03/01/2024	05:30	GlobeNewswire Inc.	Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT06 and Reference Product Eylea® (aflibercept)	NASDAQ:ALVO	Alvontech
29/11/2023	06:00	GlobeNewswire Inc.	Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®	NASDAQ:ALVO	Alvontech
28/11/2023	18:15	GlobeNewswire Inc.	Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update	NASDAQ:ALVO	Alvontech
21/11/2023	10:00	GlobeNewswire Inc.	Alvotech to Report Financial Results for the First Nine Months of 2023 on November 28, 2023, and Host Business Update Conference Call on November 29, 2023, at 8:00 am ET	NASDAQ:ALVO	Alvontech
14/11/2023	09:00	GlobeNewswire Inc.	Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki™ (AVT04), the First Biosimilar of Stelara® (ustekinumab)	NASDAQ:ALVO	Alvontech
10/11/2023	11:30	GlobeNewswire Inc.	STADA and Alvotech receive positive CHMP opinion for Europe’s first ustekinumab biosimilar to Stelara	NASDAQ:ALVO	Alvontech
07/11/2023	10:00	GlobeNewswire Inc.	Alvotech to Present at the Jefferies 2023 London Healthcare Conference	NASDAQ:ALVO	Alvontech
12/10/2023	05:00	GlobeNewswire Inc.	Alvotech Provides Update on Status of U.S. Biologics License Application for AVT04	NASDAQ:ALVO	Alvontech
03/10/2023	09:29	Business Wire	Kashiv BioSciences Enters into Exclusive Licensing Agreement with Alvotech for Development & Commercialization of a Proposed Biosimilar to Xolair® (omalizumab)	NASDAQ:ALVO	Alvontech
03/10/2023	06:00	GlobeNewswire Inc.	Alvotech Enters into Exclusive Licensing Agreement with Kashiv BioSciences for Development and Commercialization of a Proposed Biosimilar to Xolair® (omalizumab)	NASDAQ:ALVO	Alvontech